Kirk Mutafopulos
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Kirk Mutafopulos has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- David A. Weitz
John A. Paulson School of Engineering and Applied Sciences Harvard University Cambridge Massachusetts USA
5 shared publications - Pascal Spink
School of Engineering and Applied Sciences, Harvard University, Cambridge, USA
4 shared publications - Thomas Franke
Division of Biomedical Engineering, School of Engineering, University of Glasgow, Oakfield Avenue, G12 8LT Glasgow, UK
3 shared publications - Peter J. Lu
School of Engineering and Applied Sciences (SEAS), Harvard University, Cambridge, MA, USA
2 shared publications C. D. Lofstrom
Cytonome/ST, Bedford, USA
1 shared publicationChaohui Wang
State Key Laboratory for Manufacturing Systems Engineering, Xi'an Jiaotong University, Xi'an 710049, People's Republic of China
1 shared publication
Latest Publications
- Open Access
- 8 January 2025
- Published by Royal Society of Chemistry (RSC) in Lab on a Chip
- Vol. 25 (5) , 1097-1127
Challenges in blood fractionation for cancer liquid biopsy: how can microfluidics assist?
Liquid biopsy provides a minimally invasive approach to characterise the molecular and phenotypic characteristics of a patient's individual tumour by detecting evidence of cancerous change in readily available body fluids, usually the blood. When applied at multiple points during the disease journey, it can be used to monitor a patient's response to treatment and to personalise clinical management based on changes in disease burden and molecular findings. Traditional liquid biopsy approaches such as quantitative PCR, have tended to look at only a few biomarkers, and are aimed at early detection of disease or disease relapse using predefined markers. With advances in the next generation sequencing (NGS) and single-cell genomics, simultaneous analysis of both circulating tumour DNA (ctDNA) and circulating tumour cells (CTCs) is now a real possibility. To realise this, however, we need to overcome issues with current blood collection and fractionation processes. These include overcoming the need to add a preservative to the collection tube or the need to rapidly send blood tubes to a centralised processing lab with the infrastructure required to fractionate and process the blood samples. This review focuses on outlining the current state of liquid biopsy and how microfluidic blood fractionation tools can be used in cancer liquid biopsy. We describe microfluidic devices that can separate plasma for ctDNA analysis, and devices that are important in isolating the cellular component(s) in liquid biopsy, i.e., individual CTCs and CTC clusters. To facilitate a better understanding of these devices, we propose a new categorisation system based on how these devices operate. The three categories being 1) solid Interaction devices, 2) fluid Interaction devices and 3) external force/active devices. Finally, we conclude that whilst some assays and some cancers are well suited to current microfluidic techniques, new tools are necessary to support broader, clinically relevant multiomic workflows in cancer liquid biopsy.
- 8 January 2025
- Published by Royal Society of Chemistry (RSC) in Lab on a Chip
- Vol. 25 (5) , 1097-1127
Open AccessChallenges in blood fractionation for cancer liquid biopsy: how can microfluidics assist?
Liquid biopsy provides a minimally invasive approach to characterise the molecular and phenotypic characteristics of a patient's individual tumour by detecting evidence of cancerous change in readily available body fluids, usually the blood. When applied at multiple points during the disease journey, it can be used to monitor a patient's response to treatment and to personalise clinical management based on changes in disease burden and molecular findings. Traditional liquid biopsy approaches such as quantitative PCR, have tended to look at only a few biomarkers, and are aimed at early detection of disease or disease relapse using predefined markers. With advances in the next generation sequencing (NGS) and single-cell genomics, simultaneous analysis of both circulating tumour DNA (ctDNA) and circulating tumour cells (CTCs) is now a real possibility. To realise this, however, we need to overcome issues with current blood collection and fractionation processes. These include overcoming the need to add a preservative to the collection tube or the need to rapidly send blood tubes to a centralised processing lab with the infrastructure required to fractionate and process the blood samples. This review focuses on outlining the current state of liquid biopsy and how microfluidic blood fractionation tools can be used in cancer liquid biopsy. We describe microfluidic devices that can separate plasma for ctDNA analysis, and devices that are important in isolating the cellular component(s) in liquid biopsy, i.e., individual CTCs and CTC clusters. To facilitate a better understanding of these devices, we propose a new categorisation system based on how these devices operate. The three categories being 1) solid Interaction devices, 2) fluid Interaction devices and 3) external force/active devices. Finally, we conclude that whilst some assays and some cancers are well suited to current microfluidic techniques, new tools are necessary to support broader, clinically relevant multiomic workflows in cancer liquid biopsy.
- Open Access
- 23 September 2020
- Published by Royal Society of Chemistry (RSC) in Lab on a Chip
- Vol. 20 (21) , 3914-3921
Selective cell encapsulation, lysis, pico-injection and size-controlled droplet generation using traveling surface acoustic waves in a microfluidic device
We generate traveling surface acoustic waves with an interdigital transducer to create droplets on-demand; encapsulate single cells; lyse cells and immediately encapsulate their contents; and pico-inject new materials into existing droplets.
- 23 September 2020
- Published by Royal Society of Chemistry (RSC) in Lab on a Chip
- Vol. 20 (21) , 3914-3921
Open AccessSelective cell encapsulation, lysis, pico-injection and size-controlled droplet generation using traveling surface acoustic waves in a microfluidic device
We generate traveling surface acoustic waves with an interdigital transducer to create droplets on-demand; encapsulate single cells; lyse cells and immediately encapsulate their contents; and pico-inject new materials into existing droplets.
- 30 October 2019
- Published by Royal Society of Chemistry (RSC) in Lab on a Chip
- Vol. 19 (24) , 4064-4070
Rapid additive-free bacteria lysis using traveling surface acoustic waves in microfluidic channels
We report an additive-free method to lyse bacteria and extract nucleic acids and protein using a traveling surface acoustic wave (TSAW) coupled to a microfluidic device. We characterize the effects of the TSAW on E. coli by measuring the viability of cells exposed to the sound waves and find that about 90% are dead. In addition, we measure the protein and nucleic acids released from the cells and show that we recover about 20% of the total material. The lysis method should work for all types of bacteria. These results demonstrate the feasibility of using TSAW to lyse bacteria in a manner that is independent of the type of bacteria.
- 30 October 2019
- Published by Royal Society of Chemistry (RSC) in Lab on a Chip
- Vol. 19 (24) , 4064-4070
Rapid additive-free bacteria lysis using traveling surface acoustic waves in microfluidic channels
We report an additive-free method to lyse bacteria and extract nucleic acids and protein using a traveling surface acoustic wave (TSAW) coupled to a microfluidic device. We characterize the effects of the TSAW on E. coli by measuring the viability of cells exposed to the sound waves and find that about 90% are dead. In addition, we measure the protein and nucleic acids released from the cells and show that we recover about 20% of the total material. The lysis method should work for all types of bacteria. These results demonstrate the feasibility of using TSAW to lyse bacteria in a manner that is independent of the type of bacteria.
- 13 June 2019
- Published by Royal Society of Chemistry (RSC) in Lab on a Chip
- Vol. 19 (14) , 2435-2443
Traveling surface acoustic wave (TSAW) microfluidic fluorescence activated cell sorter (μFACS)
We report a microfluidic fluorescence activated cell-sorting (μFACS) device that employs traveling surface acoustic waves (TSAW) to sort cells at rates comparable to conventional jet-in-air FACS machines, with high purity and viability.
- 13 June 2019
- Published by Royal Society of Chemistry (RSC) in Lab on a Chip
- Vol. 19 (14) , 2435-2443
Traveling surface acoustic wave (TSAW) microfluidic fluorescence activated cell sorter (μFACS)
We report a microfluidic fluorescence activated cell-sorting (μFACS) device that employs traveling surface acoustic waves (TSAW) to sort cells at rates comparable to conventional jet-in-air FACS machines, with high purity and viability.
- Open Access
- 3 October 2017
- Published by Royal Society of Chemistry (RSC) in Lab on a Chip
- Vol. 17 (23) , 4059-4069
Enhanced surface acoustic wave cell sorting by 3D microfluidic-chip design
We demonstrate an acoustic wave driven microfluidic cell sorter that combines advantages of multilayer device fabrication with planar surface acoustic wave excitation.
- 3 October 2017
- Published by Royal Society of Chemistry (RSC) in Lab on a Chip
- Vol. 17 (23) , 4059-4069
Open AccessEnhanced surface acoustic wave cell sorting by 3D microfluidic-chip design
We demonstrate an acoustic wave driven microfluidic cell sorter that combines advantages of multilayer device fabrication with planar surface acoustic wave excitation.